IL127563A0 - Cell adhesion inhibiting compounds - Google Patents
Cell adhesion inhibiting compoundsInfo
- Publication number
- IL127563A0 IL127563A0 IL12756397A IL12756397A IL127563A0 IL 127563 A0 IL127563 A0 IL 127563A0 IL 12756397 A IL12756397 A IL 12756397A IL 12756397 A IL12756397 A IL 12756397A IL 127563 A0 IL127563 A0 IL 127563A0
- Authority
- IL
- Israel
- Prior art keywords
- cell adhesion
- inhibiting compounds
- adhesion inhibiting
- compounds
- cell
- Prior art date
Links
- 230000021164 cell adhesion Effects 0.000 title 1
- 150000001875 compounds Chemical class 0.000 title 1
- 230000002401 inhibitory effect Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Rheumatology (AREA)
- Pulmonology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Dermatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Immunology (AREA)
- Hospice & Palliative Care (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9613112.3A GB9613112D0 (en) | 1996-06-21 | 1996-06-21 | Chemical compounds |
| PCT/GB1997/001641 WO1997049731A1 (en) | 1996-06-21 | 1997-06-18 | Cell adhesion inhibiting compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL127563A0 true IL127563A0 (en) | 1999-10-28 |
Family
ID=10795723
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL12756397A IL127563A0 (en) | 1996-06-21 | 1997-06-18 | Cell adhesion inhibiting compounds |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US6235711B1 (ja) |
| EP (1) | EP0910582A1 (ja) |
| JP (1) | JP2000513350A (ja) |
| KR (1) | KR20000022075A (ja) |
| AU (1) | AU3102797A (ja) |
| CA (1) | CA2254995A1 (ja) |
| GB (1) | GB9613112D0 (ja) |
| HR (1) | HRP970338A2 (ja) |
| ID (1) | ID19445A (ja) |
| IL (1) | IL127563A0 (ja) |
| NO (1) | NO985966D0 (ja) |
| NZ (1) | NZ332778A (ja) |
| WO (1) | WO1997049731A1 (ja) |
| ZA (1) | ZA975436B (ja) |
Families Citing this family (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9820338D0 (en) * | 1998-09-19 | 1998-11-11 | Zeneca Ltd | Chemical compounds |
| JP2002526090A (ja) * | 1998-09-19 | 2002-08-20 | アストラゼネカ・アクチエボラーグ | インテグリンリガンド仲介疾患の診断および処置に適当なヒトのベータ１インテグリンサブユニット遺伝子における多型性 |
| BR0016818A (pt) | 1999-12-28 | 2002-10-01 | Pfizer Prod Inc | Inibidores não-peptidila de adesão celular dependente de vla-4 úteis no tratamento de doenças inflamatórias, auto-imunes e respiratórias |
| WO2001051508A1 (en) * | 2000-01-14 | 2001-07-19 | Science & Technology Corporation @ Unm | Peptide inhibitors of lfa-1/icam-1 interaction |
| US20040241689A1 (en) * | 2001-07-31 | 2004-12-02 | Baseman Joel B. | Antigens of and antibodies to translocated molecules of microorganisms and uses thereof |
| US7700565B2 (en) * | 2005-09-23 | 2010-04-20 | Nitto Denko Corporation | Peptide nucleic acid based guanidinium compounds |
| WO2007038172A2 (en) * | 2005-09-23 | 2007-04-05 | Nitto Denko Corporation | Guanidinium carriers |
| WO2007038169A2 (en) * | 2005-09-23 | 2007-04-05 | Nitto Denko Corporation | Multi-valent guanidinium compounds for molecular translocation across cellular membranes and epithelial tissues |
| AU2008219007A1 (en) | 2007-02-20 | 2008-08-28 | Merrimack Pharmaceuticals, Inc. | Methods of treating multiple sclerosis by administration of alpha-fetoprotein in combination with an integrin antagonist |
| EP2045601A1 (en) * | 2007-03-26 | 2009-04-08 | Koninklijke Philips Electronics N.V. | Use of microcarrier beads for detection and/or isolation of cells by flow cytometry and/or dielectrophoresis |
| CA2721093A1 (en) | 2008-04-11 | 2009-10-15 | Merrimack Pharmaceuticals, Inc. | Human serum albumin linkers and conjugates thereof |
| EP2547693B1 (en) | 2010-03-19 | 2015-03-11 | H. Lee Moffitt Cancer Center & Research Institute | Integrin interaction inhibitors for the treatment of cancer |
| EP2769223A1 (en) | 2011-10-17 | 2014-08-27 | Westfälische Wilhelms-Universität Münster | Assessment of pml risk and methods based thereon |
| US9273093B2 (en) * | 2012-10-11 | 2016-03-01 | Protagonist Therapeutics, Inc. | α4β7 peptide dimer antagonists |
| DK2968443T3 (da) | 2013-03-15 | 2021-12-06 | Protagonist Therapeutics Inc | Hepcidinanaloger og anvendelser deraf |
| US20140294901A1 (en) * | 2013-04-02 | 2014-10-02 | Protagonist Therapeutics, Inc. | Novel a4b7 peptide dimer antagonists |
| US20140294902A1 (en) * | 2013-04-02 | 2014-10-02 | Protagonist Therapeutics, Inc. | Novel a4b7 peptide antagonists |
| WO2015048477A1 (en) | 2013-09-27 | 2015-04-02 | H. Lee Moffitt Cancer Center And Research Institute, Inc. | Cyclic peptide conjugates and methods of use |
| GB201400292D0 (en) | 2014-01-08 | 2014-02-26 | Haemostatix Ltd | Peptide dendrimers and agents |
| WO2015176035A1 (en) | 2014-05-16 | 2015-11-19 | Protagonist Therapeutics, Inc. | α4β7 INTEGRIN THIOETHER PEPTIDE ANTAGONISTS |
| EP3169403B1 (en) | 2014-07-17 | 2024-02-14 | Protagonist Therapeutics, Inc. | Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases |
| RU2017114414A (ru) | 2014-10-01 | 2018-11-06 | Протагонист Терепьютикс, Инк. | НОВЫЕ АНТАГОНИСТЫ α4β7 НА ОСНОВЕ МОНОМЕРНЫХ И ДИМЕРНЫХ ПЕПТИДОВ |
| EP3201217A4 (en) * | 2014-10-01 | 2018-07-18 | Protagonist Therapeutics Inc. | Novel cyclic monomer and dimer peptides having integrin antagonist activity |
| US10787490B2 (en) | 2015-07-15 | 2020-09-29 | Protaganist Therapeutics, Inc. | Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases |
| US20190002503A1 (en) | 2015-12-30 | 2019-01-03 | Protagonist Therapeutics, Inc. | Analogues of hepcidin mimetics with improved in vivo half lives |
| WO2017165676A1 (en) | 2016-03-23 | 2017-09-28 | Protagonist Therapeutics, Inc. | METHODS FOR SYNTHESIZING α4β7 PEPTIDE ANTAGONISTS |
| EP3621980A4 (en) * | 2017-05-10 | 2021-06-30 | Zealand Pharma A/S | HOMODETIC CYCLIC PEPTIDES TARGETING INTEGRIN ALPHA4 BETA7 |
| US10278957B2 (en) | 2017-09-11 | 2019-05-07 | Protagonist Therapeutics, Inc. | Opioid agonist peptides and uses thereof |
| EP3749345A4 (en) | 2018-02-08 | 2022-04-06 | Protagonist Therapeutics, Inc. | CONJUGATED HEPCIDIN MIMETICS |
| AU2020311395A1 (en) | 2019-07-10 | 2022-02-03 | Protagonist Therapeutics, Inc. | Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases |
| WO2021146441A1 (en) | 2020-01-15 | 2021-07-22 | Janssen Biotech, Inc. | Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases |
| TW202237167A (zh) | 2020-11-20 | 2022-10-01 | 比利時商健生藥品公司 | 介白素-23受體之肽抑制劑組合物 |
| JP2023117892A (ja) * | 2022-02-14 | 2023-08-24 | 公益財団法人 鷹揚郷 | ヘプシジン結合ペプチド |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZW6189A1 (en) | 1988-05-09 | 1990-05-09 | Smithkline Beckman Corp | Anti-aggregatory peptides |
| NZ235563A (en) | 1989-10-13 | 1993-04-28 | Merck & Co Inc | Fibrinogen receptor antagonist and pharmaceutical composition |
| US5192746A (en) | 1990-07-09 | 1993-03-09 | Tanabe Seiyaku Co., Ltd. | Cyclic cell adhesion modulation compounds |
| US5229366A (en) | 1990-10-23 | 1993-07-20 | Fuji Photo Film Co., Ltd. | Peptide-containing polyethylene glycol derivatives and application thereof |
| IL102646A (en) | 1992-07-26 | 1996-05-14 | Yeda Res & Dev | Non-peptidic surrogates of the ldv sequence and pharmaceutical compositions comprising them |
| WO1994015958A2 (en) | 1993-01-08 | 1994-07-21 | Tanabe Seiyaku Co., Ltd. | Peptide inhibitors of cell adhesion |
| US5981478A (en) | 1993-11-24 | 1999-11-09 | La Jolla Cancer Research Foundation | Integrin-binding peptides |
| AU693143B2 (en) | 1993-12-06 | 1998-06-25 | Cytel Corporation | CS-1 peptidomimetics, compositions and methods of using the same |
| JPH10502349A (ja) * | 1994-06-29 | 1998-03-03 | テキサス・バイオテクノロジー・コーポレイシヨン | インテグリンα▲下４▼β▲下１▼のＶＣＡＭ−１またはフィブロネクチンへの結合を阻害する方法 |
| US5510332A (en) | 1994-07-07 | 1996-04-23 | Texas Biotechnology Corporation | Process to inhibit binding of the integrin α4 62 1 to VCAM-1 or fibronectin and linear peptides therefor |
| US5811391A (en) | 1994-08-25 | 1998-09-22 | Cytel Corporation | Cyclic CS-1 peptidomimetics, compositions and methods of using same |
| GB9524630D0 (en) * | 1994-12-24 | 1996-01-31 | Zeneca Ltd | Chemical compounds |
-
1996
- 1996-06-21 GB GBGB9613112.3A patent/GB9613112D0/en active Pending
-
1997
- 1997-06-18 NZ NZ332778A patent/NZ332778A/xx unknown
- 1997-06-18 JP JP10502505A patent/JP2000513350A/ja not_active Abandoned
- 1997-06-18 CA CA002254995A patent/CA2254995A1/en not_active Abandoned
- 1997-06-18 IL IL12756397A patent/IL127563A0/xx unknown
- 1997-06-18 KR KR1019980710479A patent/KR20000022075A/ko not_active Application Discontinuation
- 1997-06-18 EP EP97926150A patent/EP0910582A1/en not_active Withdrawn
- 1997-06-18 WO PCT/GB1997/001641 patent/WO1997049731A1/en not_active Application Discontinuation
- 1997-06-18 AU AU31027/97A patent/AU3102797A/en not_active Abandoned
- 1997-06-19 HR HR9613112.3A patent/HRP970338A2/xx not_active Application Discontinuation
- 1997-06-19 ZA ZA9705436A patent/ZA975436B/xx unknown
- 1997-06-20 ID IDP972121A patent/ID19445A/id unknown
-
1998
- 1998-12-18 NO NO985966A patent/NO985966D0/no not_active Application Discontinuation
- 1998-12-21 US US09/202,831 patent/US6235711B1/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| HRP970338A2 (en) | 1998-04-30 |
| ID19445A (id) | 1998-07-09 |
| CA2254995A1 (en) | 1997-12-31 |
| US6235711B1 (en) | 2001-05-22 |
| JP2000513350A (ja) | 2000-10-10 |
| NO985966L (no) | 1998-12-18 |
| AU3102797A (en) | 1998-01-14 |
| EP0910582A1 (en) | 1999-04-28 |
| ZA975436B (en) | 1997-12-22 |
| NZ332778A (en) | 2000-08-25 |
| WO1997049731A1 (en) | 1997-12-31 |
| GB9613112D0 (en) | 1996-08-28 |
| KR20000022075A (ko) | 2000-04-25 |
| NO985966D0 (no) | 1998-12-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL127563A0 (en) | Cell adhesion inhibiting compounds | |
| GB9805214D0 (en) | Cell adhesion | |
| PL324491A1 (en) | Cell adhesion inhibitors | |
| GB9607120D0 (en) | Compounds | |
| HUP9903631A3 (en) | Adhesion inhibitors | |
| GB9602326D0 (en) | Compounds | |
| EG22317A (en) | Advanced glavanic corrosion protection | |
| GB9612153D0 (en) | Compounds | |
| HK1005963A1 (en) | Galvanic cell | |
| GB9722194D0 (en) | Improved films | |
| GB9606933D0 (en) | Compounds | |
| AUPO255996A0 (en) | Cell inhibition | |
| GB9814554D0 (en) | Cell adhesion | |
| SI0805796T1 (en) | Cell adhesion inhibitors | |
| GB9607392D0 (en) | Cell modification | |
| GB9717323D0 (en) | Cell line | |
| GB9624605D0 (en) | Compound | |
| GB9607154D0 (en) | Compounds | |
| GB9612887D0 (en) | Compounds | |
| GB9614384D0 (en) | Compounds | |
| GB9607155D0 (en) | Compounds | |
| GB9614360D0 (en) | Compounds | |
| GB9607847D0 (en) | Compounds | |
| GB9607126D0 (en) | Compounds | |
| GB9607122D0 (en) | Compounds |